Apremilast Decreased Proinflammatory Cytokines and Subsequently Increased Inhibitory ones in Psoriasis: A Prospective Cohort Study
DOI:
https://doi.org/10.2340/actadv.v104.37555Keywords:
psoriasis, apremilast, cytokine, balance, pruritusAbstract
Abstract is missing (Short communication)
Downloads
References
Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007; 445: 648-651.
https://doi.org/10.1038/nature05505 DOI: https://doi.org/10.1038/nature05505
Fukasawa T, Yoshizaki A, Ebata S, Yoshizaki-Ogawa A, Asano Y, Enomoto A, et al. Single-cell-level protein analysis revealing the roles of autoantigen-reactive B lymphocytes in autoimmune disease and the murine model. Elife 2021; 10: e67209.
https://doi.org/10.7554/eLife.67209 DOI: https://doi.org/10.7554/eLife.67209
Fukasawa T, Yamashita T, Enomoto A, Yoshizaki-Ogawa A, Miyagawa K, Sato S, et al. Optimal treatments and outcome measures of palmoplantar pustulosis: A systematic review and network meta-analysis-based comparison of treatment efficacy. J Eur Acad Dermatol Venereol 2024; 38: 281-288.
https://doi.org/10.1111/jdv.19499 DOI: https://doi.org/10.1111/jdv.19499
Fukasawa T, Yoshizaki-Ogawa A, Yoshizaki A, Sato S. Impact of guselkumab on three cases of SSc accompanying psoriasis. Rheumatology (Oxford) 2024; 63: e6-e8.
https://doi.org/10.1093/rheumatology/kead287 DOI: https://doi.org/10.1093/rheumatology/kead287
Fukasawa T, Yoshizaki-Ogawa A, Enomoto A, Miyagawa K, Sato S, Yoshizaki A. Involvement of molecular mechanisms between t/b cells and IL-23: from palmoplantar pustulosis to autoimmune diseases. Int J Mol Sci 2022; 23: 8261.
https://doi.org/10.3390/ijms23158261 DOI: https://doi.org/10.3390/ijms23158261
Fukasawa T, Toyama S, Enomoto A, Yoshizaki-Ogawa A, Norimatsu Y, Tateishi S, et al. Utility of nailfold capillary assessment for predicting psoriatic arthritis based on a prospective observational cohort study. Rheumatology (Oxford) 2023; 62: 2418-2425.
https://doi.org/10.1093/rheumatology/keac664 DOI: https://doi.org/10.1093/rheumatology/keac664
Fukasawa T, Takashi Y, Enomoto A, Toyama S, Yoshizaki-Ogawa A, Tateishi S, et al. Utility of nailfold capillary assessment for predicting pustulotic arthro-osteitis in palmoplantar pustulosis based on a prospective cohort study. J Am Acad Dermatol 2023; 89: 984-991.
https://doi.org/10.1016/j.jaad.2023.07.1014 DOI: https://doi.org/10.1016/j.jaad.2023.07.1014
Schafer P. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. Biochem Pharmacol 2012; 83: 1583-1590.
https://doi.org/10.1016/j.bcp.2012.01.001 DOI: https://doi.org/10.1016/j.bcp.2012.01.001
Schafer PH, Parton A, Gandhi AK, Capone L, Adams M, Wu L, et al. Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis. Br J Pharmacol 2010; 159: 842-855.
https://doi.org/10.1111/j.1476-5381.2009.00559.x DOI: https://doi.org/10.1111/j.1476-5381.2009.00559.x
Nakao T, Kazoe Y, Mori E, Morikawa K, Fukasawa T, Yoshizaki A, et al. Cytokine analysis on a countable number of molecules from living single cells on nanofluidic devices. Analyst 2019; 144: 7200-7208.
https://doi.org/10.1039/C9AN01702J DOI: https://doi.org/10.1039/C9AN01702J
Fukasawa T, Yoshizaki A, Ebata S, Nakamura K, Saigusa R, Miura S, et al. Contribution of soluble forms of programmed death 1 and programmed death ligand 2 to disease severity and progression in systemic sclerosis. Arthritis Rheumatol 2017; 69: 1879-1890.
https://doi.org/10.1002/art.40164 DOI: https://doi.org/10.1002/art.40164
Garcet S, Nograles K, Correa da Rosa J, Schafer PH, Krueger JG. Synergistic cytokine effects as apremilast response predictors in patients with psoriasis. J Allergy Clin Immunol 2018; 142: 1010-1013.e6.
https://doi.org/10.1016/j.jaci.2018.05.039 DOI: https://doi.org/10.1016/j.jaci.2018.05.039
Dan D, Srivastava N. Psoriasis: Striving for Potential Biomarkers. Assay Drug Dev Technol 2023; 21: 235-257.
https://doi.org/10.1089/adt.2023.014 DOI: https://doi.org/10.1089/adt.2023.014
Fukasawa T, Yoshizaki-Ogawa A, Enomoto A, Miyagawa K, Sato S, Yoshizaki A. Pharmacotherapy of itch-antihistamines and histamine receptors as G protein-coupled receptors. Int J Mol Sci 2022; 23: 6579.
https://doi.org/10.3390/ijms23126579 DOI: https://doi.org/10.3390/ijms23126579
Nattkemper LA, Tey HL, Valdes-Rodriguez R, Lee H, Mollanazar NK, Albornoz C, et al. The genetics of chronic itch: gene expression in the skin of patients with atopic dermatitis and psoriasis with severe itch. J Invest Dermatol 2018; 138: 1311-1317.
https://doi.org/10.1016/j.jid.2017.12.029 DOI: https://doi.org/10.1016/j.jid.2017.12.029
Additional Files
Published
How to Cite
License
Copyright (c) 2024 Takemichi Fukasawa, Asako Yoshizaki-Ogawa, Atsushi Enomoto, Shinichi Sato, Ayumi Yoshizaki
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
